Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 71, member A pseudogene (ENSG00000261178), is categorized as a pseudogene—a region of DNA homologous to the FAM71A gene but does not encode a functional protein[3]. While traditionally considered "junk DNA," recent research suggests that pseudogenes can sometimes be transcribed into noncoding RNAs with possible regulatory roles, such as acting as microRNA decoys or occasionally generating small interfering RNAs that can modulate gene expression, particularly in the context of cancer[1][4]. However, this regulatory activity is not universal, and most pseudogenes, including ENSG00000261178, are not considered conventional druggable targets. Their clinical and pharmacological significance remains limited relative to protein-coding genes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 71, member A pseudogene (ENSG00000261178).